Although SP-D demonstrated protective efficacy in immunosuppressed murine models challenged with A. fumigatus conidia, enhancing fungal clearance, the available evidence does not support SP-D as a diagnostic or prognostic biomarker in COPD–PA (154). The gene discussed is SFTPD; the disease is chronic obstructive pulmonary disease.